Skip to Content

Keratoconus — Symptoms, Stages, Cross-Linking & Treatment 2026

15 May 2026 by
Keratoconus — Symptoms, Stages, Cross-Linking & Treatment 2026
AGAAZ OPHTHALMICS, Girish Dave
Keratoconus — Symptoms, Stages, Cross-Linking & Treatment (2026) | Agaaz Ophthalmics
Agaaz Ophthalmics · Eye Health Education
15 May 2026 21 min read 8 clinical refs

Most keratoconus patients hear about their diagnosis years after the disease started. A teenager who kept updating their glasses prescription. A young adult whose vision never quite corrected properly. By the time topography is done and the cone is seen, progression may already have stolen corneal tissue that doesn't come back.

This guide is published by Agaaz Ophthalmics — an ophthalmic products manufacturer based in Ahmedabad, India, whose products are used in surgical and diagnostic procedures across 15+ countries. We write these guides because understanding eye conditions at depth leads to better decisions, earlier treatment, and preserved vision.

Keratoconus is particularly prevalent in India, UAE, Saudi Arabia, Pakistan, and across the Middle East and North Africa — regions where Agaaz Ophthalmics has active clinical relationships. Awareness matters enormously: a teenager in Mumbai or Dubai with keratoconus caught early and treated with cross-linking can preserve excellent vision for life. The same teenager seen five years later may need a corneal transplant.

Who this guide is written for: People who have been diagnosed with keratoconus or suspect they have it. Parents of teenagers with rapidly changing prescriptions. Anyone in a high-risk group (atopic conditions, family history, habitual eye rubbing). Optometrists and ophthalmologists can share it with patients. The level is educational — it does not replace a clinical consultation and corneal topography scan.

Section 01

What Is Keratoconus — What's Actually Happening to the Cornea

The cornea is the clear, dome-shaped front surface of the eye. In a healthy eye, the cornea is uniformly curved and smooth — it bends (refracts) light precisely onto the retina, producing a clear image. In keratoconus, the corneal stroma (the middle layer, which makes up 90% of corneal thickness) loses collagen and structural integrity in a localised area, usually the central or inferior (lower) cornea.

As the cornea loses structural support in this area, intraocular pressure — the normal fluid pressure inside the eye — pushes the weakened zone outward. The result is a progressive, irregular, cone-shaped protrusion. This irregular shape scatters light entering the eye, producing distorted, blurred, and double vision that standard spectacle lenses cannot fully correct, because they can only correct for regular (symmetric) refractive error, not irregular astigmatism.

The word keratoconus comes from Greek: kéras (cornea) + konos (cone). It typically begins in the teenage years or early twenties and can progress for 10–20 years before naturally stabilising, usually in the mid-thirties. StatPearls describes it as "a progressive bilateral corneal ectatic disorder characterized by cone-like steepening of the cornea."

Section 02

What Keratoconus Looks Like — Corneal Topography

Corneal topography is the primary diagnostic tool for keratoconus. It creates a colour-coded map of the cornea's curvature — like a weather map, but for the front of your eye. Use the visualiser below to see how the topography changes between a healthy cornea and different stages of keratoconus.

Corneal Topography Visualiser
Simulated — shows curvature pattern, not real clinical data
Normal cornea
Curvature (D)
55+ D Steep
50–54 D
46–49 D
42–45 D Normal
39–41 D
<38 D Flat
Section 03

Symptoms — What Patients Actually Experience

Keratoconus is notorious for being missed or delayed in diagnosis, because its early symptoms mimic normal myopia and astigmatism. The warning signs that should trigger topography are:

  • Frequent prescription changes — needing new glasses every few months rather than once a year or two. Glasses that corrected vision 6 months ago are no longer working.
  • Vision that glasses can't fully correct — best corrected visual acuity is declining even with the "right" prescription. This happens because irregular astigmatism cannot be corrected by sphero-cylindrical spectacle lenses.
  • Monocular diplopia ("ghosting") — seeing a double or smeared image in one eye alone. This is different from binocular diplopia (two eyes, brain issue) — keratoconus causes the corneal irregularity to split light in one eye.
  • Halos and starbursts around lights — particularly at night. Street lights or car headlights appear to streak or bloom.
  • Increased light sensitivity (photophobia) — difficulty in bright light or sunlight.
  • Eye rubbing — itching from allergies drives rubbing, which drives keratoconus, which causes eye discomfort, which drives more rubbing. A self-reinforcing cycle in atopic patients.

Stop rubbing your eyes — this is not optional

  • Eye rubbing is the single most important modifiable risk factor for keratoconus. A multivariable analysis found eye rubbing carries an odds ratio of 4.93 — nearly 5 times greater risk of keratoconus development in habitual eye rubbers.
  • Rubbing causes micro-trauma to corneal collagen fibres, releasing enzymes that degrade corneal stroma, weakening the structure that prevents the cone from forming.
  • The itch-rub-damage cycle is especially dangerous in atopic patients (eczema, hay fever, allergic rhinitis) — the itching is real and the urge to rub is overwhelming. Treat the allergy instead. Antihistamine eye drops, oral antihistamines, and cool compresses relieve the itch without the mechanical trauma.
  • Contact lens wearers: never rub the eye with lenses in, and avoid rubbing when removing lenses — this is a common high-risk moment.
  • Parents: teach children not to rub their eyes, especially if they have eczema or hay fever. Keratoconus often begins in childhood before any symptoms are noticed.
Section 04

Who Gets Keratoconus — Risk Factors and Why India and the Middle East Are Hotspots

Keratoconus is not randomly distributed. Certain populations are dramatically more affected than others — and the reasons matter for understanding and prevention.

Keratoconus risk factors and relative risk levels
Risk FactorRelative RiskMechanismActionable?
Habitual eye rubbing~5× higher (OR 4.93)Mechanical corneal collagen degradationYes — stop rubbing, treat allergy
Family history of KC~25× higher (OR 25.52)Genetic predisposition to corneal collagen weaknessPartial — early screening
Atopic conditions (eczema, hayfever)3–4× higherItching drives eye rubbing; inflammatory mediatorsYes — aggressively treat atopy
South Asian / Middle Eastern ethnicity2–4× higher prevalenceGenetic and environmental combined; higher UV; higher atopyPartial — early screening
Down syndromeVery high (up to 15%)Connective tissue abnormality; frequent eye rubbingScreening essential
Connective tissue disordersElevatedCollagen structural abnormality (Ehlers-Danlos, Marfan)Partial — early screening
Consanguineous parentage~3× higher (OR 2.89)Higher frequency of homozygous genetic risk variantsAwareness — early screening
Floppy eyelid syndromeElevatedMechanical corneal trauma during sleepYes — treat FES

The concentration of keratoconus in South Asian and Middle Eastern populations is striking and clinically important. The prevalence of keratoconus has been estimated to be between 0.2 and 4,790 per 100,000 persons, with individuals of Middle Eastern and Asian ethnicities being most affected. In India, reported prevalence reaches 2.3% in some clinical series — more than 10 times the commonly cited global figure of 0.2%. In UAE and Saudi Arabia, KC is a major ophthalmology workload and one of the leading indications for corneal topography in young patients.

Family history screening rule: If one member of a family has keratoconus, all first-degree relatives (parents, siblings, children) should have corneal topography. The familial relative risk is approximately 25-fold, making routine sibling and offspring screening one of the highest-yield actions in corneal disease prevention. Subclinical keratoconus (forme fruste) can be detected by topography years before any symptoms appear — and cross-linked early.

Section 05

The Four Stages of Keratoconus

The Amsler-Krumeich grading system is the most widely used classification. Understanding your stage helps you understand what treatments are appropriate and what your visual prognosis looks like.

Stage 1 — Mild
Early keratoconus
Mild irregular astigmatism. Glasses may still partially correct vision. Topography shows early inferior steepening. No corneal scarring. No significant thinning. Most patients are unaware anything is wrong.
Max K reading<48 D
TreatmentCXL if progressing
Vision correctionGlasses or soft CL
Stage 2 — Moderate
Progressive distortion
Glasses increasingly inadequate. Significant irregular astigmatism. Contact lens fitting more complex — RGP or hybrid lenses usually needed. Topography shows clear inferior cone. Minimum corneal thickness >400 µm — CXL still possible.
Max K reading48–54 D
TreatmentCXL + scleral CL
Vision correctionRGP / hybrid / scleral
Stage 3 — Advanced
Significant vision loss
Marked irregular astigmatism with significant reduction in best corrected vision. Corneal thinning and possible early scarring. Scleral lenses often still effective. INTACS (intracorneal ring segments) may help flatten the cone. CXL more complex at this stage.
Max K reading54–55 D
TreatmentINTACS + CXL + scleral
Transplant?Approaching decision
Stage 4 — Severe
Transplant territory
Extreme corneal steepening, severe irregular astigmatism, corneal scarring, and/or significant thinning. Contact lenses no longer tolerated or inadequate. Corneal transplantation (DALK or PK) is the primary option for visual rehabilitation.
Max K reading>55 D
TreatmentDALK or PK
Visual prognosisGood post-transplant
Section 06

Treatment — Every Option Explained

The treatment approach for keratoconus is determined by two questions: Is the disease still progressing? And can vision still be adequately corrected with non-surgical optical means? Here is the full treatment spectrum, from mildest to most invasive.

Stage 1–2
Mild
Spectacles and soft contact lenses
In early keratoconus, glasses or soft toric contact lenses may still provide acceptable vision. This is a temporary strategy — as KC progresses, regular soft lenses lose effectiveness because the irregular surface cannot be matched by a flexible lens conforming to the cone shape.
Stage 1 onlyTemporaryMonitor topography every 6 months
Stage 1–3
All stages
Corneal collagen cross-linking (CXL) — arrest, not reverse
CXL is the most important intervention in keratoconus. It does not improve vision — it stops the disease from getting worse. Riboflavin (vitamin B2) drops are instilled into the de-epithelialised cornea for 20–30 minutes, then UV-A light is applied for the same duration. The photochemical reaction creates additional covalent bonds between collagen fibres, dramatically increasing corneal biomechanical stiffness. The standard Dresden protocol has approximately 95% effectiveness in halting progression. It is most effective in Stage 1–2. Minimum corneal thickness requirement: 400 µm for standard protocol.
Gold standard for progressionEpi-off or epi-on protocols30–60 min procedure1–2 weeks recovery
Stage 2–3
Mod–Adv
Rigid Gas-Permeable (RGP) and scleral contact lenses
Hard contact lenses create a smooth optical surface over the irregular cornea by filling the gap between the rigid lens and the cornea with tears. This optical correction can be excellent even with significantly abnormal topography. Scleral lenses — larger lenses that vault entirely over the cornea and rest on the sclera — have become the gold standard for moderate-advanced KC. They are more comfortable than RGPs, provide excellent vision, and can be worn by patients who find RGPs intolerable. Fitting is specialised and requires an experienced keratoconus contact lens practitioner.
Scleral lenses preferredDaily wearSpecialist fitting needed
Stage 2–3
Adjunct
INTACS — intracorneal ring segments
Small crescent-shaped plastic rings are surgically inserted into the mid-peripheral cornea to mechanically flatten the cone, reducing corneal steepening and improving the regularity of the central optical zone. INTACS reduce corneal curvature enough to improve best corrected vision and sometimes make contact lens fitting easier. They are not a substitute for CXL — often used in combination. Removable if needed.
Improves contact lens toleranceReduces K readingsOften combined with CXL
Stage 3–4
Advanced
DALK — Deep Anterior Lamellar Keratoplasty
The most modern corneal transplant for keratoconus. The front layers of the cornea (epithelium, stroma) are replaced with donor tissue, while the patient's own Descemet's membrane and endothelium are preserved. This eliminates endothelial rejection risk — the most feared long-term complication of full-thickness transplants. DALK results for keratoconus are excellent, with most patients achieving good vision (often requiring a hard contact lens post-op). Recovery takes 12–18 months.
Preferred over PK in KCNo endothelial rejection12–18 months recovery
Stage 4
Severe
PK — Penetrating Keratoplasty (full-thickness transplant)
All layers of the patient's cornea are replaced with full-thickness donor tissue. Used when DALK is not possible (corneal perforation, endothelial disease, technical failure). Results in keratoconus are generally good but risk of endothelial rejection persists for life — patients require lifelong immunosuppressive eye drops and monitoring. Long-term graft survival is approximately 90% at 5 years but declines over decades.
Last resort after DALK consideredLifelong rejection monitoring90% 5-yr graft survival

"The cross-linking method has shown approximately 95 percent effectiveness in stopping the progression of keratoconus. Corneal crosslinking is generally recommended for patients in the beginning stages of keratoconus — this is due to the fact that the cornea at this point is not yet significantly irregularly shaped and vision problems are generally not severe."

Optometrists.org — Keratoconus Treatment: Corneal Cross-Linking · Evidence review based on multiple clinical trials
Section 07

Keratoconus and Cataract Surgery — A Critical Intersection

Many patients with keratoconus develop cataracts in later life, presenting a uniquely complex surgical challenge. This is a critical topic that concerns both the patient and the ophthalmic team.

  • IOL power calculation is significantly less accurate in keratoconic eyes. Standard keratometry-based formulas assume a regular corneal surface — in KC, the irregular topography introduces significant errors. Modern tomography-based formulas and ray-tracing calculations are needed. Post-operative refraction is less predictable.
  • Premium IOLs (multifocal, EDOF) are generally contraindicated in patients with significant keratoconus. These lenses require a regular optical surface to deliver their multi-focal effect — the irregular corneal optics of KC destroy this. Standard monofocal IOLs are the appropriate choice.
  • Toric IOLs require special caution — the irregular astigmatism of KC is not the same as regular corneal astigmatism, and a toric IOL axis calculated from standard topography may be unreliable.
  • Cataract surgery does not treat or worsen keratoconus — but removing a cataract in a keratoconic eye requires a very experienced cataract surgeon who understands the limitations of biometry in irregular corneas.
  • Agaaz OP-VIEW AS hydrophobic IOL and OP-FOLD AS hydrophilic IOL are appropriate monofocal choices for cataract surgery in mild-moderate keratoconic eyes. Both provide clear, spherical correction without the optical complexity of premium designs.

Stabilise KC before refractive or cataract surgery: In patients with active (progressing) keratoconus, corneal cross-linking should be performed before any refractive surgery (LASIK is contraindicated in KC) or elective cataract surgery where possible. Operating on a progressing KC eye risks unpredictable outcomes as the corneal shape continues to change post-operatively. Confirm topographic stability for at least 12 months before elective surgery if possible.

Section 08

Frequently Asked Questions

Is keratoconus hereditary?
Yes — significantly. A first-degree relative with keratoconus increases your risk approximately 25-fold. The genetic component is real and likely involves multiple genes affecting corneal collagen. However, having the genetic predisposition does not guarantee you will develop KC — environmental factors, particularly eye rubbing, appear to be the trigger that converts genetic susceptibility into actual disease. If one family member has keratoconus, all first-degree relatives should have corneal topography screening, even without symptoms.
Keratoconus rarely causes complete blindness, but it can cause severe vision impairment that significantly impacts quality of life. Advanced untreated keratoconus can lead to corneal scarring, extreme irregular astigmatism, and vision that cannot be corrected by any contact lens. Corneal hydrops — a rupture of Descemet's membrane causing sudden severe corneal swelling — is a painful acute complication that can lead to scarring. However, with modern treatment (cross-linking, scleral lenses, corneal transplantation), the vast majority of keratoconus patients retain useful vision throughout their lives. Early diagnosis and treatment dramatically improve the prognosis.
Yes — keratoconus naturally tends to stabilise in the mid-thirties, when corneal collagen becomes more cross-linked as part of normal ageing. However, this stabilisation can take 10–20 years from onset, during which significant corneal tissue can be lost. Cross-linking dramatically accelerates this stabilisation artificially, at a much earlier age and with much less corneal damage. Waiting for natural stabilisation in a young patient with progressive KC is generally not accepted as good medical practice when cross-linking is available and affordable.
No — LASIK is contraindicated in keratoconus. LASIK removes corneal tissue (already weak in KC) and the flap creation weakens corneal biomechanics further. Performing LASIK on a keratoconic eye can cause catastrophic post-LASIK ectasia — rapid corneal bulging and vision loss worse than the original keratoconus. Pre-LASIK screening specifically aims to detect keratoconus and exclude affected patients. If you have been told you are a LASIK candidate but have symptoms suggesting keratoconus (frequent prescription changes, ghosting, unusual astigmatism), insist on corneal topography and tomography before proceeding.
Yes — keratoconus is significantly more prevalent in South Asian (India, Pakistan, Bangladesh, Sri Lanka) and Middle Eastern (UAE, Saudi Arabia, Kuwait, Iran, Egypt) populations than in Northern European populations. Reported prevalence in India reaches 2–2.3% in some series — more than 10 times the commonly cited global average. In UAE, keratoconus is one of the most common corneal conditions seen at tertiary ophthalmology centres. The reasons are likely multi-factorial: genetic predisposition, higher rates of atopic conditions driving eye rubbing, greater UV exposure, and possibly dietary factors affecting collagen quality. In these regions, any young patient with rapidly changing refraction or best-corrected visual acuity below normal should be considered for topographic screening.
Standard (epi-off) cross-linking involves removing the corneal epithelium, which causes significant pain and light sensitivity for 3–5 days while it heals. A bandage contact lens is fitted immediately after the procedure to protect the healing surface. Vision may be blurry for 1–4 weeks. Most patients return to work or school within 1–2 weeks. Vision may temporarily worsen in the first 3 months as the treated cornea restructures — this is normal and usually resolves. Final topographic outcome is assessed at 6–12 months. Epi-on (transepithelial) CXL involves less pain but evidence shows it is less effective than the Dresden epi-off protocol.
Section 09

Keratoconus Across Agaaz's Markets

The regions where Agaaz Ophthalmics operates are precisely those where keratoconus has the highest impact.

  • India: With a reported prevalence of 2–2.3% and a population of 1.4 billion, India potentially has tens of millions of people with keratoconus. Yet access to topography and cross-linking remains limited outside urban tertiary centres. Agaaz's OVD products (PURE-HYAL) and surgical solutions are used in corneal procedures including DALK across India. Awareness of KC among general ophthalmologists is a key public health gap.
  • UAE and Saudi Arabia: These markets have the clinical infrastructure and patient awareness for advanced KC management. Scleral lens fitting, INTACS, cross-linking, and DALK are all performed at major centres. In the United Arab Emirates, retinopathy has been shown to be present in 19% of the diabetic population, with diabetes identified in up to 40% of individuals aged over 55 years — and the same atopic conditions driving KC are prevalent. Agaaz supplies to UAE ophthalmology centres.
  • Nigeria, Kenya, South Africa: KC is present but severely underdiagnosed due to limited topography access. Most KC patients in Sub-Saharan Africa are managed with spectacles until surgical intervention becomes unavoidable. Affordable cross-linking services, where they exist, are transformative.
  • Philippines, Vietnam, Indonesia, Malaysia: Southeast Asian KC prevalence is rising with improving diagnosis. Access to scleral lenses and cross-linking is improving at tertiary centres in Manila, Ho Chi Minh City, and Jakarta.
Section 10

Related Guides from Agaaz Ophthalmics

All published on Beyond Vision — ophthalmic education from Agaaz Ophthalmics, India's precision eye care manufacturer.

For surgeons, hospitals & distributors
Precision IOLs and ophthalmic products — from Agaaz

Agaaz Ophthalmics manufactures intraocular lenses, OVDs, surgical dyes, intracameral antibiotics, and silicone oils — exported to 15+ countries from Ahmedabad since 2003. View full portfolio →

Summary

The Key Points

  • Keratoconus is a progressive corneal disease in which the cornea thins and bulges into a cone shape, distorting vision in ways spectacles cannot fully correct. It typically affects both eyes, starts in the teens, and can progress for 10–20 years.
  • Eye rubbing is the #1 modifiable risk factor. OR 4.93. Stop rubbing. Treat the allergy causing itching. Teach children not to rub their eyes — especially if they have eczema, hay fever, or family history.
  • Family history carries 25× higher risk. Screen all first-degree relatives of KC patients with corneal topography, even without symptoms.
  • Keratoconus is much more common in India, UAE, Saudi Arabia, Pakistan, and the Middle East than in Western populations. Anyone with rapidly changing refraction in these regions should have topographic screening.
  • Cross-linking (CXL) arrests progression in 95% of cases. It does not reverse the disease but prevents further loss. It is most effective in Stage 1–2 when corneal tissue is still relatively healthy. Early diagnosis enables early CXL.
  • Vision management: Soft lenses (early) → RGP lenses (moderate) → scleral lenses (moderate-advanced) → INTACS (adjunct) → DALK or PK (severe).
  • LASIK is absolutely contraindicated in keratoconus — it can cause catastrophic ectasia.
  • In keratoconus patients who need cataract surgery: monofocal IOLs only, careful biometry with tomography-based formulas, experienced surgeon essential. Do not use multifocal or EDOF IOLs.

Clinical References

  1. Torres Netto EA, Al-Otaibi WM et al. Keratoconus Diagnosis and Treatment: Recent Advances. Eye and Vision. 2023;10(1):1–18. PMC10511017 →
  2. Schlegel Z, Hoang-Xuan T, Gatinel D. Keratoconus. StatPearls. Treasure Island (FL). Updated 2024. NCBI →
  3. Alió JL, Barraquer RI et al. Management of keratoconus: an updated review. Frontiers in Medicine. 2023;10:1212314. Frontiers →
  4. Sanderson H, Sykakis E. Corneal Cross-Linking. EyeWiki. Updated March 2026. EyeWiki →
  5. Kuźmiński M et al. A Review of Keratoconus Cross-Linking Treatment Methods. PMC. 2025. PMC11899953 →
  6. Hashemi H, Khabazkhoob M, Fotouhi A. Topographic keratoconus is not necessarily a risk factor for laser in situ keratomileusis. J Cataract Refract Surg. 2013;39(3):359–366.
  7. Idrees S, Sridhar MS, Sharma S. Keratoconus: an update on clinical, molecular and genetic aspects. Acta Ophthalmologica. 2023.
  8. Cleveland Clinic. Keratoconus. Updated 2023. ClevelandClinic →

This article is for patient education only. Corneal topography by a qualified ophthalmologist or optometrist is required for diagnosis. Clinical decisions about cross-linking, contact lens fitting, and surgical options must be made with your treating specialist based on your individual topographic data and clinical findings.

Start writing here...